Persistence of Metabolic Monitoring for Psychiatry Inpatients Treated With Second-Generation Antipsychotics Utilizing a Computer-Based Intervention

Journal of Clinical Pharmacy and Therapeutics - United Kingdom
doi 10.1111/jcpt.12368
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Metabolic Monitoring of Psychiatric Patients on Second-Generation Antipsychotics

Annals of General Psychiatry
PsychiatryMental Health
2008English

Second-Generation Antipsychotics and Metabolic Side-Effects: Canadian Population-Based Study

BJPsych Open
PsychiatryMental Health
2018English

Monitoring Metabolic Side Effects When Initiating Treatment With Second-Generation Antipsychotic Medication

Clinical Schizophrenia and Related Psychoses
MedicinePsychiatryMental Health
2012English

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Lower Serum BCL-2 Protein Levels in Schizophrenia Patients Treated With the Second Than the First Generation Antipsychotics

Acta Medica Medianae
2017English

Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

American Journal of Psychiatry
PsychiatryMental Health
2016English

A Randomized Controlled Trial Undertaken to Test a Nurse-Led Weight Management and Exercise Intervention Designed for People With Serious Mental Illness Who Take Second Generation Antipsychotics

Journal of Advanced Nursing
Nursing
2012English

Prescribing Antipsychotics in Child Psychiatry

Psychiatric Bulletin
1999English

Metabolic Effects of Treatment With Atypical Antipsychotics

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy